Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Salbutamol in Obese Patients Undergoing Laparoscopic Bariatric Surgery
NCT07378605Not yet recruiting
- Sponsor
- Gazi Yaşargil Training and Research Hospital
- Start
- Jan 2026
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of salbutamol in obesity (2 arms), sponsored by Gazi Yaşargil Training and Research Hospital. Primary endpoint: Change in intraoperative mechanical power. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
salbutamol
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07378605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07378605.